WASHINGTON, D.C. — US health authorities on Thursday approved updated versions of Pfizer and Moderna's Covid-19 vaccines, with the companies saying the jabs will be available "in the coming days."

The latest vaccines, developed using the KP.2 variant of the virus, are designed to target variants currently in circulation and provide better protection against the risks of hospitalization or death, the US Food and Drug Administration (FDA) said.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here